H.R. 5950 · 117th Congress
Improving Patient Access to Care and Treatment Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DeanSponsor6 cosponsors · 2 D, 4 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
What it does: CRS summary · Introduced in House · Nov 12, 2021
Improving Patient Access to Care and Treatment Act
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Improving Patient Access to Care and Treatment Act
Latest action (Nov 1, 2022): Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Nov 12, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.